Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Aster Vandierendonck
Profile
Projects
Publications
Activities
Awards & Distinctions
11
Results
2021
NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
Aster Vandierendonck
Helena Degroote
Bart Vanderborght
Xavier Verhelst
Anja Geerts
Lindsey Devisscher
Hans Van Vlierberghe
A1
Journal Article
in
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2021
2020
Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model
Sanne Van Campenhout
Laurentijn Tilleman
Sander Lefere
Aster Vandierendonck
Sarah Raevens
Xavier Verhelst
Anja Geerts
Filip Van Nieuwerburgh
Hans Van Vlierberghe
Lindsey Devisscher
A1
Journal Article
in
METABOLISM-CLINICAL AND EXPERIMENTAL
2020
2019
Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease
Sander Lefere
Frederique Van de Velde
Anne Hoorens
Sarah Raevens
Sanne Van Campenhout
Aster Vandierendonck
Sara Neyt
Bert Vandeghinste
Christian Vanhove
Charlotte Debbaut
et al.
A1
Journal Article
in
HEPATOLOGY
2019
Myeloid-specific IRE1 alpha deletion reduces tumour development in a non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model
Sanne Van Campenhout
Sander Lefere
Aster Vandierendonck
Xavier Verhelst
Anja Geerts
Hans Van Vlierberghe
Lindsey Devisscher
C3
Conference
2019
2018
Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis
Sander Lefere
Frederique Van de Velde
Sarah Raevens
Sanne Van Campenhout
Aster Vandierendonck
S Neyt
Christian Vanhove
Anne Hoorens
Christophe Casteleyn
Xavier Verhelst
et al.
C3
Conference
2018
Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis
Sander Lefere
F Van de Velde
Sarah Raevens
Sanne Van Campenhout
Aster Vandierendonck
Sara Neyt
Christian Vanhove
Anne Hoorens
CHRISTINE CASTELEYN
Xavier Verhelst
et al.
C3
Conference
2018
Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in non-alcoholic fatty liver disease
Sander Lefere
Frederique Van de Velde
Anne Hoorens
Sarah Raevens
Sanne Van Campenhout
Aster Vandierendonck
Sara Neyt
Bert Vandeghinste
Christian Vanhove
Charlotte Debbaut
et al.
C3
Conference
2018
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
Daniela Pollutri
Clarissa Patrizi
Sara Marinelli
Catia Giovannini
Elena Trombetta
Ferdinando A Giannone
Maurizio Baldassarre
Santina Quarta
Yves-Paul Vandewynckel
Aster Vandierendonck
et al.
A1
Journal Article
in
CELL DEATH & DISEASE
2018
2016
Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma
Yves-Paul Vandewynckel
Céline Coucke
Debby Laukens
Lindsey Devisscher
Annelies Paridaens
Eliene Bogaerts
Aster Vandierendonck
Sarah Raevens
Xavier Verhelst
Christophe Van Steenkiste
et al.
A1
Journal Article
in
ONCOTARGET
2016
Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma
Yves-Paul Vandewynckel
Céline Coucke
Debby Laukens
Lindsey Devisscher
Annelies Paridaens
Eliene Bogaerts
Aster Vandierendonck
Sarah Raevens
Xavier Verhelst
Christophe Van Steenkiste
et al.
C3
Conference
2016
The unfolded protein response underlies microenvironmental stress-induced phenotype switching leading to stemness and chemoresistance in human hepatocellular carcinoma
Yves-Paul Vandewynckel
O Govaere
Aster Vandierendonck
Debby Laukens
Lindsey Devisscher
Annelies Paridaens
Eliene Bogaerts
Sarah Raevens
Xavier Verhelst
Christophe Van Steenkiste
et al.
C3
Conference
2016